Bilateral retinal vein occlusion associated with 5,10-methylenetetrahydrofolate reductase mutation.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9402832.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To report on the occurrence of 5,10-methylenetetrahydrofolate reductase (MTHFR) deficiency, known to cause mild to moderate hyperhomocystinemia and increased risk of vascular occlusive disease, in a young patient with bilateral central retinal vein occlusion. A 25-year-old man was initially examined with central retinal vein occlusion in the right eye, followed 4 months later by a central retinal vein occlusion in the left eye. Studies for risk factors predisposing to thrombosis were performed. Hematologic studies failed to detect any pathology. However, the patient was found to be homozygous for 677C-T mutation in MTHFR enzyme. Central retinal vein occlusion may be associated with a mutation in MTHFR.
Medical subject headings
- Hematinics
- Oxidoreductases
- Point Mutation
- Retinal Vein Occlusion